Maxigesic® PE
Cold, Flu, and Sinus Relief
ApprovedCommercial - Launched in New Zealand
Key Facts
Indication
Cold, Flu, and Sinus Relief
Phase
Approved
Status
Commercial - Launched in New Zealand
Company
About AFT Pharmaceuticals
AFT Pharmaceuticals is a publicly listed, integrated pharmaceutical company with a mission to develop and commercialize innovative products that address unmet health needs. Founded in 1997, it has achieved consistent revenue growth by leveraging a dual strategy of in-licensing/distribution and proprietary R&D, most notably with its world-first Maxigesic® combination analgesic platform. The company has successfully expanded from its New Zealand base to establish a significant presence in Australia, Asia, and Europe, demonstrating robust commercial execution and a focus on niche therapeutic areas like pain management, ophthalmology, and gastroenterology.
View full company profile